Literature DB >> 34727208

Differential proteome profile, biological pathways, and network relationships of osteogenic proteins in calcified human aortic valves.

Richard I Han1,2, Chenyue W Hu1, David S Loose3, Li Yang4, Li Li5, Jennifer P Connell1, Michael J Reardon6, Gerald M Lawrie6, Amina A Qutub7, Joel D Morrisett2, K Jane Grande-Allen8.   

Abstract

Calcific aortic valve disease (CAVD) is the most common heart valve disease requiring intervention. Most research on CAVD has focused on inflammation, ossification, and cellular phenotype transformation. To gain a broader picture into the wide range of cellular and molecular mechanisms involved in this disease, we compared the total protein profiles between calcified and non-calcified areas from 5 human valves resected during surgery. The 1413 positively identified proteins were filtered down to 248 proteins present in both calcified and non-calcified segments of at least 3 of the 5 valves, which were then analyzed using Ingenuity Pathway Analysis. Concurrently, the top 40 differentially abundant proteins were grouped according to their biological functions and shown in interactive networks. Finally, the abundance of selected osteogenic proteins (osteopontin, osteonectin, osteocalcin, osteoprotegerin, and RANK) was quantified using ELISA and/or immunohistochemistry. The top pathways identified were complement system, acute phase response signaling, metabolism, LXR/RXR and FXR/RXR activation, actin cytoskeleton, mineral binding, nucleic acid interaction, structural extracellular matrix (ECM), and angiogenesis. There was a greater abundance of osteopontin, osteonectin, osteocalcin, osteoprotegerin, and RANK in the calcified regions than the non-calcified ones. The osteogenic proteins also formed key connections between the biological signaling pathways in the network model. In conclusion, this proteomic analysis demonstrated the involvement of multiple signaling pathways in CAVD. The interconnectedness of these pathways provides new insights for the treatment of this disease.
© 2021. Springer Japan KK, part of Springer Nature.

Entities:  

Keywords:  Aortic valve; Calcification; Pathways; Proteomics

Mesh:

Substances:

Year:  2021        PMID: 34727208     DOI: 10.1007/s00380-021-01975-z

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  46 in total

1.  Proteomic profile of human aortic stenosis: insights into the degenerative process.

Authors:  Tatiana Martín-Rojas; Felix Gil-Dones; Luis F Lopez-Almodovar; Luis R Padial; Fernando Vivanco; Maria G Barderas
Journal:  J Proteome Res       Date:  2012-02-16       Impact factor: 4.466

2.  Differential proteoglycan and hyaluronan distribution in calcified aortic valves.

Authors:  Elizabeth H Stephens; Jerome G Saltarrelli; L Scott Baggett; Indrajit Nandi; Joyce J Kuo; Alan R Davis; Elizabeth A Olmsted-Davis; Michael J Reardon; Joel D Morrisett; Kathryn Jane Grande-Allen
Journal:  Cardiovasc Pathol       Date:  2010-12-24       Impact factor: 2.185

Review 3.  Calcific aortic valve disease: not simply a degenerative process: A review and agenda for research from the National Heart and Lung and Blood Institute Aortic Stenosis Working Group. Executive summary: Calcific aortic valve disease-2011 update.

Authors:  Nalini M Rajamannan; Frank J Evans; Elena Aikawa; K Jane Grande-Allen; Linda L Demer; Donald D Heistad; Craig A Simmons; Kristyn S Masters; Patrick Mathieu; Kevin D O'Brien; Frederick J Schoen; Dwight A Towler; Ajit P Yoganathan; Catherine M Otto
Journal:  Circulation       Date:  2011-10-18       Impact factor: 29.690

Review 4.  Vascular calcification: pathobiology of a multifaceted disease.

Authors:  Linda L Demer; Yin Tintut
Journal:  Circulation       Date:  2008-06-03       Impact factor: 29.690

5.  Calcification and extracellular matrix dysregulation in human postmortem and surgical aortic valves.

Authors:  M Victoria Gomez-Stallons; Justin T Tretter; Keira Hassel; Osniel Gonzalez-Ramos; Dorothy Amofa; Nicholas J Ollberding; Wojciech Mazur; Joseph K Choo; J Michael Smith; Dean J Kereiakes; Katherine E Yutzey
Journal:  Heart       Date:  2019-06-05       Impact factor: 5.994

6.  Extracellular matrix remodeling and organization in developing and diseased aortic valves.

Authors:  Robert B Hinton; Joy Lincoln; Gail H Deutsch; Hanna Osinska; Peter B Manning; D Woodrow Benson; Katherine E Yutzey
Journal:  Circ Res       Date:  2006-04-27       Impact factor: 17.367

7.  Bone formation and inflammation in cardiac valves.

Authors:  E R Mohler; F Gannon; C Reynolds; R Zimmerman; M G Keane; F S Kaplan
Journal:  Circulation       Date:  2001-03-20       Impact factor: 29.690

8.  Differential expression of cartilage and bone-related proteins in pediatric and adult diseased aortic valves.

Authors:  Elaine E Wirrig; Robert B Hinton; Katherine E Yutzey
Journal:  J Mol Cell Cardiol       Date:  2010-12-14       Impact factor: 5.000

9.  Spatiotemporal Multi-Omics Mapping Generates a Molecular Atlas of the Aortic Valve and Reveals Networks Driving Disease.

Authors:  Florian Schlotter; Arda Halu; Shinji Goto; Mark C Blaser; Simon C Body; Lang H Lee; Hideyuki Higashi; Daniel M DeLaughter; Joshua D Hutcheson; Payal Vyas; Tan Pham; Maximillian A Rogers; Amitabh Sharma; Christine E Seidman; Joseph Loscalzo; Jonathan G Seidman; Masanori Aikawa; Sasha A Singh; Elena Aikawa
Journal:  Circulation       Date:  2018-07-24       Impact factor: 29.690

10.  iTRAQ proteomic analysis of extracellular matrix remodeling in aortic valve disease.

Authors:  Tatiana Martin-Rojas; Laura Mourino-Alvarez; Sergio Alonso-Orgaz; Esther Rosello-Lleti; Enrique Calvo; Luis Fernando Lopez-Almodovar; Miguel Rivera; Luis R Padial; Juan Antonio Lopez; Fernando de la Cuesta; Maria G Barderas
Journal:  Sci Rep       Date:  2015-12-01       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.